Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
30,173 total articles
Rocket Lab USA's stock climbed 5% on Monday after favorable analyst commentary and upgraded price targets. Stifel raised its target to $105 while maintaining a Buy rating, matching the Street High, and Cantor Fitzgerald reiterated an Overweight rating with an $85 target. Management's comments at the Space Symposium and recent product and acquisitio…
Arcus Biosciences said an Independent Data Monitoring Committee recommended stopping the Phase 3 STAR-121 study in first-line metastatic non-small cell lung cancer for futility, prompting a roughly 4% decline in the company’s stock. The decision affects the domvanalimab-plus-zimberelimab combination versus pembrolizumab plus chemotherapy, and prece…
Nektar Therapeutics' stock climbed 20% following the release of 52-week results from its Phase 2b REZOLVE-AA trial of rezpegaldesleukin in patients with severe-to-very-severe alopecia areata. The extension-phase data show a higher proportion of patients achieving predefined scalp-hair coverage thresholds versus placebo, and the company said the saf…
Members of the family that controls Brown-Forman Corp., the maker of Jack Daniel's, are reported to prefer a potential sale to French distiller Pernod Ricard SA rather than an offer from U.S. competitor Sazerac Co. Discussions under consideration would tilt heavily toward stock consideration, and would be structured to increase the family's ownersh…
Stocks across market-cap segments recorded sharp moves on Monday as deal headlines, analyst upgrades and corporate disclosures influenced share prices. Topbuild surged after a $17 billion acquisition announcement, Kaspi.kz climbed, and a mix of technology, biotech and special-purpose acquisition companies logged both meaningful gains and declines. …
Evercore ISI analyst Amit Daryanani added Arista Networks and IBM to the firm's tactical outperform list as both companies approach first-quarter earnings. Evercore cites beat-and-raise setups: for IBM, a potential revenue and EPS upside tied in part to the earlier-than-expected close of the Confluent acquisition; for Arista, stronger AI demand, ga…
Wolfe Research’s valuation study finds that major managed care companies are projected to earn well below their target margins in 2026, with shortfalls ranging from roughly one-third to four times the targets. Molina, Humana, and Centene show the largest gaps, while CVS Health, Elevance Health, and UnitedHealth Group also report substantial underpe…
Renewed tensions between Washington and Tehran over the weekend have complicated hopes for a permanent ceasefire, analysts at Wolfe Research say. U.S. actions, including the seizure of an Iranian-flagged vessel, and mixed signals from Iranian authorities have left the Strait of Hormuz effectively closed to commercial traffic. With a two-week pause …
Agnico Eagle Mines said it will acquire Rupert Resources and Aurion Resources and purchase B2Gold's 70% stake in the Fingold joint venture, moves that give the company full control of a contiguous land package in Finland's Central Lapland Greenstone Belt. The combination integrates the Ikkari gold project with Agnico's existing Kittila mine and con…
On April 20, Adobe announced CX Enterprise, a collection of AI-driven tools aimed at automating and personalizing digital marketing for corporate clients. The launch comes as software stocks face selling pressure amid investor concern about autonomous AI offerings from startups such as Anthropic and OpenAI. Adobe reported a 2.2% rise in morning tra…
RBC Capital Markets downgraded GitLab to sector perform from outperform and trimmed its price target to $25 from $33, highlighting a series of near-term challenges that are expected to constrain upside. While the firm remains constructive on GitLab's longer-term position as a DevSecOps platform, it flagged several revenue and sales risks, and said …
Agios Pharmaceuticals stock dropped 25% after Novo Nordisk announced positive trial results for its experimental sickle cell therapy etavopivat. Novo reported a 27% reduction in vaso-occlusive crisis events and roughly a four-month delay to the first such event versus standard of care. Agios is pursuing an accelerated approval path with the FDA for…
Equity markets have seen pronounced moves in recent months, with large trading profits for investment banks amid Middle East-related volatility and a particularly strong performance in April for stocks identified by an AI-driven InvestingPro strategy. The service is offering a limited-time sale of up to 55% off, while multiple AI picks have produce…
The Federal Reserve’s vice chair for supervision, Michelle Bowman, has indicated to senior bank executives that regulators do not anticipate a repeat of last year’s intensive industry campaign to resist tougher capital requirements. Fed officials have circulated softened drafts of the "Basel III" and "GSIB surcharge" rules that the central bank say…
Goldman Sachs pushed back on negative market sentiment toward Apple ahead of the company's fiscal second-quarter results, arguing that recent share weakness overstates the risks. The bank models EPS of $2.00, above the Street consensus of $1.93, and expects outperformance in iPhone and Mac revenue, gross margins and Services growth. Goldman also hi…
GlobalFoundries shares climbed 8% on Monday after reports that United Microelectronics Corp. (UMC) plans to raise wafer prices in the second half of the year. UMC told customers the move reflects an evolving supply-demand balance and continued investment needs, while Morgan Stanley upgraded UMC and now models multi-year price increases tied to impr…
Global air travel continues to face major disruption after the Iran war prompted the closure of key Middle Eastern hubs, including Dubai, Doha and Abu Dhabi. Dozens of airlines have suspended or cancelled services to cities across the region and beyond, with disruption timelines stretching into May, June, July and in some cases October. Carriers ha…
Friday's Form 4 filings disclosed a mix of insider purchases across a range of issuers and sizeable share disposals tied to Magnetar-related entities at CoreWeave. Transactions included purchases by System1's CFO, a portfolio manager's stake in a CBRE infrastructure term fund, dividend reinvestment at Primoris, repeated buys at Spruce Power's share…
Tesla has received approval in the Netherlands for a supervised full self-driving (FSD) system to operate on city streets, the first such clearance in Europe. The move drew praise from early adopters who call it a safety advance and concerns from cycling groups and some city officials who worry the technology may struggle with the complexity of Ams…
Saudi Arabia's equity benchmark, the Tadawul All Share, ended the trading session down 0.85% as losses in Media & Publishing, Building & Construction and Energy & Utilities weighed on the market. Decliners outpaced advancers by a wide margin, with notable declines among healthcare, cable manufacturing and media groups. Meanwhile, oil benchmarks ros…
Futures tied to Canada’s primary equity gauge dipped Monday as renewed frictions between the United States and Iran undercut earlier optimism that the Strait of Hormuz had reopened to commercial traffic. U.S. futures also pointed lower, while oil surged and gold eased amid shifting assessments about the longevity of a potential ceasefire and confli…
UBS regards the European food and household and personal care (HPC) sector as attractive due to relatively low valuations, limited direct exposure to the Middle East and a strong capacity to transfer higher commodity costs to consumers. The broker singled out Reckitt Benckiser and Danone as its preferred stocks, while noting near-term risks includi…
Affiliates of Blue Owl Capital's real assets arm will buy Sila Realty Trust in an all-cash transaction valued at roughly $2.4 billion. The agreement prices Sila at $30.38 per share, a 19% premium to its April 17 closing price of $25.53. Sila owns 137 properties and three undeveloped land parcels across 65 U.S. markets; the deal signals further expa…
Anthropic has introduced Mythos, its most capable AI model to date, through a tightly controlled preview that reportedly uncovered "thousands" of significant vulnerabilities across major operating systems and web browsers. Access has been provided to large technology firms and over 40 organizations responsible for critical software infrastructure. …
UBS has downgraded BBVA from buy to neutral and lowered its 12-month price target to €20.5 from €22.3, citing constrained potential for further earnings upgrades and valuation rerating. The move follows modest downward adjustments to EPS estimates for 2026-2028 and heightened concern over Turkey's macro path after a sharp rise in oil prices. UBS no…
